Pinto Shelly's Form 4 filing
Alx Oncology Holdings Inc (ALXO) · filed Jan 2, 2025
- Accession no.
- 0001415889-25-000132
- Filed
- Jan 2, 2025
- Trade date
- Dec 30, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $2.25K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pinto ShellyCIK 0001857740 | Officer (Interim CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | Common Stock | SSaleDisposed | −1,426 | $1.58 | −$2,253.08 | 90,123 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.